UniProt ID | DHB12_HUMAN | |
---|---|---|
UniProt AC | Q53GQ0 | |
Protein Name | Very-long-chain 3-oxoacyl-CoA reductase {ECO:0000305} | |
Gene Name | HSD17B12 {ECO:0000312|HGNC:HGNC:18646} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 312 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
Protein Description | Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate in the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation.. | |
Protein Sequence | MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAVVTGSTDGIGKSYAEELAKHGMKVVLISRSKDKLDQVSSEIKEKFKVETRTIAVDFASEDIYDKIKTGLAGLEIGILVNNVGMSYEYPEYFLDVPDLDNVIKKMININILSVCKMTQLVLPGMVERSKGAILNISSGSGMLPVPLLTIYSATKTFVDFFSQCLHEEYRSKGVFVQSVLPYFVATKLAKIRKPTLDKPSPETFVKSAIKTVGLQSRTNGYLIHALMGSIISNLPSWIYLKIVMNMNKSTRAHYLKKTKKN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Ubiquitination | SALPAAGFLYWVGAG CCCCCCCEEEECCHH | 3.97 | 22817900 | |
12 | Ubiquitination | LPAAGFLYWVGAGTV CCCCCEEEECCHHHH | 8.86 | 21890473 | |
12 | Phosphorylation | LPAAGFLYWVGAGTV CCCCCEEEECCHHHH | 8.86 | - | |
21 | Ubiquitination | VGAGTVAYLALRISY CCHHHHHHHHHHHHH | 6.54 | 22817900 | |
23 | Ubiquitination | AGTVAYLALRISYSL HHHHHHHHHHHHHHH | 5.11 | 22817900 | |
25 | Ubiquitination | TVAYLALRISYSLFT HHHHHHHHHHHHHHH | 15.36 | 22817900 | |
27 | Phosphorylation | AYLALRISYSLFTAL HHHHHHHHHHHHHHH | 11.39 | 21406692 | |
28 | Phosphorylation | YLALRISYSLFTALR HHHHHHHHHHHHHHH | 13.66 | 21406692 | |
29 | Phosphorylation | LALRISYSLFTALRV HHHHHHHHHHHHHHH | 15.37 | 21406692 | |
32 | Phosphorylation | RISYSLFTALRVWGV HHHHHHHHHHHHHCC | 30.03 | 21406692 | |
43 | Ubiquitination | VWGVGNEAGVGPGLG HHCCCCCCCCCCCCC | 23.21 | 22817900 | |
45 | Ubiquitination | GVGNEAGVGPGLGEW CCCCCCCCCCCCCCE | 12.32 | 22817900 | |
52 | Ubiquitination | VGPGLGEWAVVTGST CCCCCCCEEEEECCC | 7.80 | 22817900 | |
54 | Ubiquitination | PGLGEWAVVTGSTDG CCCCCEEEEECCCCC | 4.08 | 21890473 | |
63 | Ubiquitination | TGSTDGIGKSYAEEL ECCCCCCCHHHHHHH | 20.56 | 22817900 | |
65 | Ubiquitination | STDGIGKSYAEELAK CCCCCCHHHHHHHHH | 25.10 | 22817900 | |
66 | Phosphorylation | TDGIGKSYAEELAKH CCCCCHHHHHHHHHC | 22.86 | - | |
67 | Ubiquitination | DGIGKSYAEELAKHG CCCCHHHHHHHHHCC | 15.75 | 22817900 | |
72 | Acetylation | SYAEELAKHGMKVVL HHHHHHHHCCCEEEE | 54.00 | 26822725 | |
81 | Phosphorylation | GMKVVLISRSKDKLD CCEEEEEECCHHHHH | 26.75 | 29514088 | |
83 | Phosphorylation | KVVLISRSKDKLDQV EEEEEECCHHHHHHH | 38.11 | 29514088 | |
84 | Malonylation | VVLISRSKDKLDQVS EEEEECCHHHHHHHC | 58.74 | 26320211 | |
84 | Ubiquitination | VVLISRSKDKLDQVS EEEEECCHHHHHHHC | 58.74 | 21906983 | |
85 | Ubiquitination | VLISRSKDKLDQVSS EEEECCHHHHHHHCH | 58.98 | 22817900 | |
86 | 2-Hydroxyisobutyrylation | LISRSKDKLDQVSSE EEECCHHHHHHHCHH | 58.67 | - | |
86 | Malonylation | LISRSKDKLDQVSSE EEECCHHHHHHHCHH | 58.67 | 26320211 | |
86 | Ubiquitination | LISRSKDKLDQVSSE EEECCHHHHHHHCHH | 58.67 | 22817900 | |
87 | Ubiquitination | ISRSKDKLDQVSSEI EECCHHHHHHHCHHH | 8.80 | 22817900 | |
91 | Phosphorylation | KDKLDQVSSEIKEKF HHHHHHHCHHHHHHH | 19.34 | 21406692 | |
92 | Phosphorylation | DKLDQVSSEIKEKFK HHHHHHCHHHHHHHC | 44.47 | 21406692 | |
95 | Ubiquitination | DQVSSEIKEKFKVET HHHCHHHHHHHCCEE | 51.29 | 21906983 | |
97 | Ubiquitination | VSSEIKEKFKVETRT HCHHHHHHHCCEEEE | 45.54 | 22817900 | |
99 | Ubiquitination | SEIKEKFKVETRTIA HHHHHHHCCEEEEEE | 50.67 | 22817900 | |
104 | Phosphorylation | KFKVETRTIAVDFAS HHCCEEEEEEEECCC | 22.25 | 21406692 | |
107 | Ubiquitination | VETRTIAVDFASEDI CEEEEEEEECCCHHH | 5.71 | 22817900 | |
111 | Phosphorylation | TIAVDFASEDIYDKI EEEEECCCHHHHHHH | 35.48 | 21406692 | |
115 | Phosphorylation | DFASEDIYDKIKTGL ECCCHHHHHHHHHCC | 24.41 | 21406692 | |
117 | Acetylation | ASEDIYDKIKTGLAG CCHHHHHHHHHCCCC | 29.18 | 20167786 | |
117 | Ubiquitination | ASEDIYDKIKTGLAG CCHHHHHHHHHCCCC | 29.18 | 21906983 | |
119 | Ubiquitination | EDIYDKIKTGLAGLE HHHHHHHHHCCCCCC | 42.13 | 22817900 | |
149 | Ubiquitination | EYFLDVPDLDNVIKK HHHCCCCCHHHHHHH | 67.51 | 21890473 | |
164 | Ubiquitination | MININILSVCKMTQL HHCCCHHHHHHHHHC | 22.98 | 21890473 | |
164 | Phosphorylation | MININILSVCKMTQL HHCCCHHHHHHHHHC | 22.98 | 20068231 | |
167 | Ubiquitination | INILSVCKMTQLVLP CCHHHHHHHHHCCCC | 42.71 | 22817900 | |
169 | Phosphorylation | ILSVCKMTQLVLPGM HHHHHHHHHCCCCCC | 12.30 | - | |
170 | Ubiquitination | LSVCKMTQLVLPGMV HHHHHHHHCCCCCCH | 26.52 | 21890473 | |
175 | Ubiquitination | MTQLVLPGMVERSKG HHHCCCCCCHHCCCC | 28.71 | 22817900 | |
181 | Ubiquitination | PGMVERSKGAILNIS CCCHHCCCCEEEEEC | 59.59 | 21906983 | |
183 | Ubiquitination | MVERSKGAILNISSG CHHCCCCEEEEECCC | 13.56 | 21890473 | |
187 | Ubiquitination | SKGAILNISSGSGML CCCEEEEECCCCCCC | 2.88 | 21890473 | |
191 | Ubiquitination | ILNISSGSGMLPVPL EEEECCCCCCCCHHH | 23.99 | 21890473 | |
206 | Ubiquitination | LTIYSATKTFVDFFS HHHHHHCHHHHHHHH | 39.42 | 21890473 | |
209 | Ubiquitination | YSATKTFVDFFSQCL HHHCHHHHHHHHHHH | 8.31 | 22817900 | |
212 | Ubiquitination | TKTFVDFFSQCLHEE CHHHHHHHHHHHCHH | 4.22 | 21890473 | |
217 | Ubiquitination | DFFSQCLHEEYRSKG HHHHHHHCHHHHHCC | 33.21 | 22817900 | |
223 | Ubiquitination | LHEEYRSKGVFVQSV HCHHHHHCCCCHHHH | 50.52 | 21890473 | |
225 | Ubiquitination | EEYRSKGVFVQSVLP HHHHHCCCCHHHHHH | 4.96 | 21890473 | |
229 | Ubiquitination | SKGVFVQSVLPYFVA HCCCCHHHHHHHHHH | 21.96 | 21890473 | |
233 | Phosphorylation | FVQSVLPYFVATKLA CHHHHHHHHHHHHHH | 13.41 | - | |
237 | Ubiquitination | VLPYFVATKLAKIRK HHHHHHHHHHHHCCC | 22.68 | 24816145 | |
238 | Ubiquitination | LPYFVATKLAKIRKP HHHHHHHHHHHCCCC | 36.39 | 21906983 | |
241 | Ubiquitination | FVATKLAKIRKPTLD HHHHHHHHCCCCCCC | 54.18 | 22817900 | |
244 | Ubiquitination | TKLAKIRKPTLDKPS HHHHHCCCCCCCCCC | 45.91 | 22817900 | |
244 | Malonylation | TKLAKIRKPTLDKPS HHHHHCCCCCCCCCC | 45.91 | 26320211 | |
246 | Phosphorylation | LAKIRKPTLDKPSPE HHHCCCCCCCCCCHH | 51.10 | 25002506 | |
249 | 2-Hydroxyisobutyrylation | IRKPTLDKPSPETFV CCCCCCCCCCHHHHH | 50.97 | - | |
249 | Ubiquitination | IRKPTLDKPSPETFV CCCCCCCCCCHHHHH | 50.97 | 22817900 | |
251 | Phosphorylation | KPTLDKPSPETFVKS CCCCCCCCHHHHHHH | 40.90 | 23312004 | |
254 | Phosphorylation | LDKPSPETFVKSAIK CCCCCHHHHHHHHHH | 36.79 | 25002506 | |
257 | Ubiquitination | PSPETFVKSAIKTVG CCHHHHHHHHHHHHC | 29.94 | 27667366 | |
258 | Phosphorylation | SPETFVKSAIKTVGL CHHHHHHHHHHHHCC | 29.89 | 25002506 | |
261 | Ubiquitination | TFVKSAIKTVGLQSR HHHHHHHHHHCCCCC | 36.55 | 27667366 | |
279 | Ubiquitination | YLIHALMGSIISNLP HHHHHHHHHHHHCCC | 19.28 | 24816145 | |
299 | Ubiquitination | KIVMNMNKSTRAHYL HHHHCCCHHHHHHHH | 42.30 | 29967540 | |
311 | Ubiquitination | HYLKKTKKN------ HHHHHHCCC------ | 73.46 | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DHB12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DHB12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DHB12_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AFG32_HUMAN | AFG3L2 | physical | 26344197 | |
AT1A1_HUMAN | ATP1A1 | physical | 26344197 | |
ATPG_HUMAN | ATP5C1 | physical | 26344197 | |
COPB_HUMAN | COPB1 | physical | 26344197 | |
ETFA_HUMAN | ETFA | physical | 26344197 | |
FAS_HUMAN | FASN | physical | 26344197 | |
ENPL_HUMAN | HSP90B1 | physical | 26344197 | |
PHB_HUMAN | PHB | physical | 26344197 | |
RAB1B_HUMAN | RAB1B | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
QCR2_HUMAN | UQCRC2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...